Onsy S. Ayad, MD, FAAP

Onsy S. Ayad, MD, is Director of the Pediatric ECMO program, Associate Medical Director of the Pediatric Intensive Care Unit at Nationwide Children’s Hospital and PCCM Critical Care Liaison to the Stecker Scholarship Program in the Department of Pediatric Education at Nationwide Children’s Hospital and a Clinical Associate Professor of Pediatrics at The Ohio State University College of Medicine. Dr. Ayad attended the Alexandria University College of Medicine in Alexandria, Egypt, and completed an internship and residency at Cooper Hospital/ University Medical Center, Camden, New Jersey. He completed a fellowship in pediatric critical care medicine at Cincinnati Children’s Hospital Medical Center in Cincinnati, Ohio. Clinical research and educational activities include vasopressin deficiency in children following cardiopulmonary bypass, incidence and outcome, vasopressin deficiency in children with septic shock and the effect of enteral feeding with OxepaTM on the clinical outcome of children with acute lung injury.

Gender:

• Male

Languages Spoken:

• English
• Arabic

Research Center:

• Hospital-Based Research Faculty

Graduate School

• Alexandria University - Egypt
  Date Completed: 11/01/1983

Internship

• Cooper Hospital University Medical Center - Camden, NJ
  Date Completed: 06/30/1993

Residency

• Cooper Hospital University Medical Center - Camden, NJ
  Date Completed: 06/30/1995

Fellowship

• Cincinnati Children's Hospital Medical Center
  Date Completed: 06/30/1998

Department:

• Pediatrics

Section:

• Critical Care

Specialty:

• Pediatric Critical Care
  
• Pediatrics
  

Date of Appointment at Nationwide Children’s Hospital:

• 11/17/1998

• Karsies, Todd, McClead, Rick, Evans, Laura, Frost, Randy, Ayad, Onsy. 2013. 563: A protocolized approach can improve inhaled nitric oxide use in the pediatric intensive care unit. In The 43rd Critical Care Congress
• Karsies, T; McClead, R; Evans, L; Frost, R; Ayad, O. 2013. A protocolized approach can improve inhaled nitric oxide use in the pediatric intensive care unit. In 43rd Annual Critical Care Congress
• 2013. Multidisciplinary Quality Improvement Initiative to Reduce Ventilator-Associated Tracheobronchitis in the PICU.  PEDIATRIC CRITICAL CARE MEDICINE. Vol. 14, no. 5. (June 1).
• Muszynski, JA; Sartori, J; Steele, L; Frost, R; Wang, W; Khan, N; Lee, A; Lin, A; Hall,Mark,W; Ayad, O. 2013. Multidisciplinary Quality Improvement Initiative to Reduce Ventilator-Associated Tracheobronchitis in the PICU.  PEDIATRIC CRITICAL CARE MEDICINE. Vol. 14, no. 5. (June): 533-538.
• Jacobs, BR; Nadkarni, V; Goldstein, B; Checchia, P; Ayad, O; Bean, J; DeMichele, S. 2013. Nutritional Immunomodulation in Critically Ill Children With Acute Lung Injury: Feasibility and Impact on Circulating Biomarkers.  PEDIATRIC CRITICAL CARE MEDICINE. Vol. 14, no. 1. (January): e45-e56.
• Jacobs, BR; Nadkarni, V; Goldstein, B; Checchia, P; Ayad, O; Bean, J; DeMichele, S. 2013. Nutritional Immunomodulation in Critically Ill Children With Acute Lung Injury: Feasibility and Impact on Circulating Biomarkers.  PEDIATRIC CRITICAL CARE MEDICINE. Vol. 14, no. 1. (January 1): e45-e56-e45-e56.
• Jacobs BR, Nadkarni V, Goldstein B, Checchia P, Ayad O, Bean J, DeMichele S. 2013. Nutritional immunomodulation in critically ill children with acute lung injury: feasibility and impact on circulating biomarkers.  Ped Crit Care Med. Vol. 14, no. 1. (January): e45-56.
• Jacobs BR, Nadkarni V, Goldstein B, Checchia P, Ayad O, Bean J, Demichele S. 2013. Nutritional Immunomodulation in Critically Ill Children With Acute Lung Injury: Feasibility and Impact on Circulating Biomarkers.  Pediatric Critical Care Medicine. Vol. 14, no. 1. (January 1): E45-E56-E45-E56.
• Jacobs BR, Nadkarni V, Goldstein B, Checchia P, Ayad O, Bean J, Demichele S. 2013. Nutritional Immunomodulation in Critically Ill Children With Acute Lung Injury: Feasibility and Impact on Circulating Biomarkers.  Pediatric Critical Care Medicine. Vol. 14, no. 1. (January): E45-E56.
• 2013. Nutritional Immunomodulation in Critically Ill Children With Acute Lung Injury: Feasibility and Impact on Circulating Biomarkers.  PEDIATRIC CRITICAL CARE MEDICINE. Vol. 14, no. 1. (January 1).
• Ayad O. 2009. Negative pressure ventilation. In Clinical Guideline for Mechanical Ventilation. Newton, PA: Handbooks in Health Care Co..
• Ayad O. 2009. Negative pressure ventilation. In Clinical Guideline for Mechanical Ventilation.
• 2008. Extracorporeal Membrane Oxygenation.  EMERGENCY MEDICINE CLINICS OF NORTH AMERICA. Vol. 26, no. 4. (November 1).
• Ayad, Onsy; Dietrich, Ann; Mihalov, Leslie. 2008. Extracorporeal Membrane Oxygenation.  EMERGENCY MEDICINE CLINICS OF NORTH AMERICA. Vol. 26, no. 4. (November 1): 953-959-953-959.
• Ayad O, Dietrich A, Mihalov L. 2008. Extracorporeal membrane oxygenation.  Emerg Med Clin North Am. Vol. 26, no. 4. (November 1): 953-9-953-9.
• Ayad, Onsy; Dietrich, Ann; Mihalov, Leslie. 2008. Extracorporeal Membrane Oxygenation.  EMERGENCY MEDICINE CLINICS OF NORTH AMERICA. Vol. 26, no. 4. (November): 953-959.
• Ayad O, Dietrich A, Mihalov L. 2008. Extracorporeal membrane oxygenation.  Emerg Med Clin North Am. Vol. 26, no. 4. (November): 953-9.
• Ayad O; Dietrich A; Mihalov L. 2008. Extracorporeal Membrane Oxygenation.  Emerg Med Clin North Am. Vol. 26, no. 4. (November): 953-959.
• Preston, TJ; Olshove, VF; Ayad, O; Nicol, KK; Riley, JB. 2008. Novoseven use in a non-cardiac pediatric ECMO patient with uncontrolled bleeding.  J Extra Corpor Technol. Vol. 40, no. 2. (June 1): 123-126-123-126.
• Preston, TJ; Olshove, VF; Ayad, O; Nicol, KK; Riley, JB. 2008. Novoseven use in a non-cardiac pediatric ECMO patient with uncontrolled bleeding.  The Journal of extra-corporeal technology. Vol. 40, no. 2. (June 1): 123-126-123-126.
• Preston, TJ; Olshove, VF; Ayad, O; Nicol, KK; Riley, JB. 2008. Novoseven use in a non-cardiac pediatric ECMO patient with uncontrolled bleeding.  J Extra Corpor Technol. Vol. 40, no. 2. (June): 123-126.
• Preston, TJ; Olshove, VF; Ayad, O; Nicol, KK; Riley, JB. 2008. Novoseven use in a non-cardiac pediatric ECMO patient with uncontrolled bleeding.  The Journal of extra-corporeal technology. Vol. 40, no. 2. (June): 123-126.
• 2008. Novoseven use in a non-cardiac pediatric ECMO patient with uncontrolled bleeding.  Journal of Extra-Corporeal Technology. Vol. 40, no. 2. (June 1).
• Nadkarni,V; DeMichele,S; Goldstein,B; Checchia,P; Ayad,O; Jacobs,B,R. 2005. Safety of an enteral formula enriched with eicosapentaenoic and gamma-linolenic acids in critically ill children with acute lung injury. In 35th Critical Care Congress of the Society-of-Critical-Care-Medicine
• Jacobs,B; Shanley,T; Page,K; Nadkarni,V; Goldstein,B; Checchia,P; Ayad,O; DeMichele,S. 2005. Bronchoalveolar lavage inflammatory characteristics of children with ARDS. In 35th Critical Care Congress of the Society of Critical Care Medicine
• Jacobs, BR; Nadkarni, V; Goldstein, B; Checchia, P; Ayad, O; DeMichele, S. 2005. Clinical characteristics and outcome in children with ARDS. In 35th Critical Care Congress of the Society-of-Critical-Care-Medicine
• Jacobs, B.; Shanley, T.; Page, K.; Nadkarni, V.; Goldstein, B.; Checchia, P.; Ayad, O.; DeMichele, S. 2005. Bronchoalveolar lavage inflammatory characteristics of children with ARDS. In 35th Critical Care Congress of the Society-of-Critical-Care-Medicine
• Jacobs,B; Shanley,T; Page,K; Nadkarni,V; Goldstein,B; Checchia,P; Ayad,O; DeMichele,S. 2005. Bronchoalveolar lavage inflammatory characteristics of children with ARDS. In 35th Critical Care Congress of the Society of Critical Care Medicine
• 2005. Safety of an enteral formula enriched with eicosapentaenoic and gamma-linolenic acids in critically ill children with acute lung injury. In 35th Critical Care Congress of the Society-of-Critical-Care-Medicine
• Jacobs, B; Shanley, T; Page, K; Nadkarni, V; Goldstein, B; Checchia, P; Ayad, O; DeMichele, S. 2005. Bronchoalveolar lavage inflammatory characteristics of children with ARDS. In 35th Critical Care Congress of the Society of Critical Care Medicine
• Nadkarni,V; DeMichele,S; Goldstein,B; Checchia,P; Ayad,O; Jacobs,B,R. 2005. Safety of an enteral formula enriched with eicosapentaenoic and gamma-linolenic acids in critically ill children with acute lung injury. In 35th Critical Care Congress of the Society-of-Critical-Care-Medicine
• Nadkarni,V; DeMichele,S; Goldstein,B; Checchia,P; Ayad,O; Jacobs,B,R. 2005. Safety of an enteral formula enriched with eicosapentaenoic and gamma-linolenic acids in critically ill children with acute lung injury. In 35th Critical Care Congress of the Society-of-Critical-Care-Medicine
• Jacobs, B.R.; Nadkarni, V.; Goldstein, B.; Checchia, P.; Ayad, O.; DeMichele, S. 2005. Clinical characteristics and outcome in children with ARDS. In 35th Critical Care Congress of the Society-of-Critical-Care-Medicine
• 2005. Clinical characteristics and outcome in children with ARDS. In 35th Critical Care Congress of the Society-of-Critical-Care-Medicine
• Nadkarni,V; DeMichele,S; Goldstein,B; Checchia,P; Ayad,O; Jacobs,B,R. 2005. Safety of an enteral formula enriched with eicosapentaenoic and gamma-linolenic acids in critically ill children with acute lung injury. In 35th Critical Care Congress of the Society-of-Critical-Care-Medicine
• Jacobs, B.R.; Nadkarni, V.; Goldstein, B.; Checchia, P.; Ayad, O.; DeMichele, S. 2005. Clinical characteristics and outcome in children with ARDS. In 35th Critical Care Congress of the Society-of-Critical-Care-Medicine
• 2005. Bronchoalveolar lavage inflammatory characteristics of children with ARDS. In 35th Critical Care Congress of the Society-of-Critical-Care-Medicine
• Jacobs,B,R; Nadkarni,V; Goldstein,B; Checchia,P; Ayad,O; DeMichele,S. 2005. Clinical characteristics and outcome in children with ARDS. In 35th Critical Care Congress of the Society-of-Critical-Care-Medicine
• Ayad,O; Stark,J,M; Fiedler,M,M; Menendez,I,Y; Ryan,M,A; Wong,H,R. 1998. The heat shock response inhibits RANTES gene expression in cultured human lung epithelium.  Journal of Immunology. Vol. 161, no. 5. (September): 2594-2599.
• Ayad O; Stark JM; Fiedler MM; Menendez IY; Ryan MA; Wong HR. 1998. The heat shock response inhibits RANTES gene expression in cultured human lung epithelium.  J Immunol. Vol. 161, no. 5. (September): 2594-9.
• Ayad, O., Stark, J. M., Fiedler, M. M., Menendez, I. Y., Ryan, M. A., Wong, H. R. 1998. The heat shock response inhibits RANTES gene expression in cultured human lung epithelium.  J Immunol. Vol. 161, no. 5. (September 1): 2594-9-2594-9. PubMed ID: 9725261
• Ayad, O., Stark, J. M., Fiedler, M. M., Menendez, I. Y., Ryan, M. A., Wong, H. R. 1998. The heat shock response inhibits RANTES gene expression in cultured human lung epithelium.  J Immunol. Vol. 161, no. 5. (September): 2594-9. PubMed ID: 9725261
• 1998. The heat shock response inhibits RANTES gene expression in cultured human lung epithelium.  JOURNAL OF IMMUNOLOGY. Vol. 161, no. 5. (September 1).
• Ayad,O; Stark,J,M; Fiedler,M,M; Menendez,I,Y; Ryan,M,A; Wong,H,R. 1998. The heat shock response inhibits RANTES gene expression in cultured human lung epithelium.  Journal of Immunology. Vol. 161, no. 5. (September 1): 2594-2599-2594-2599.
• Ayad O, Wong HR. 1998. Nitric oxide decreases surfactant protein A gene expression in H441 cells.  Critical Care Medicine. Vol. 26, no. 7. (July 1): 1277-1282-1277-1282.
• Ayad, O; Wong, HR. 1998. Nitric oxide decreases surfactant protein a gene expression in H441 cells.  CRITICAL CARE MEDICINE. Vol. 26, no. 7. (July 1): 1277-1282-1277-1282.
• 1998. Nitric oxide decreases surfactant protein a gene expression in H441 cells.  CRITICAL CARE MEDICINE. Vol. 26, no. 7. (July 1).
• Ayad O, Wong HR. 1998. Nitric oxide decreases surfactant protein A gene expression in H441 cells.  Critical Care Medicine. Vol. 26, no. 7. (July): 1277-1282.
• Ayad, O; Wong, HR. 1998. Nitric oxide decreases surfactant protein a gene expression in H441 cells.  CRITICAL CARE MEDICINE. Vol. 26, no. 7. (July): 1277-1282.
• Ayad, O; Wong, HR. 1998. Nitric oxide decreases surfactant protein a gene expression in H441 cells.  Crit Care Med. Vol. 26, no. 7. (July): 1277-1282.
• Ayad,O; Wong,H,R. 1998. Nitric oxide decreases surfactant protein a gene expression in H441 cells. In Society-of-Critical-Care-Medicine 26th Educational and Scientific Symposium
• Ayad, O., Wong, H. R. 1998. Nitric oxide decreases surfactant protein A gene expression in H441 cells.  Critical Care Medicine. Vol. 26, no. 7. (January 1): 1277-82-1277-82. PubMed ID: 9671381
• Ayad, O., Wong, H. R. 1998. Nitric oxide decreases surfactant protein A gene expression in H441 cells.  Critical Care Medicine. Vol. 26, no. 7. (January): 1277-82. PubMed ID: 9671381
• Muszynski, Jennifer A. MD; Sartori, James RN, BSN; Steele, Lisa RN, BSN. Multidisciplinary Quality Improvement Initiative to Reduce Ventilator-Associated Tracheobronchitis in the PICU.  Critical Care Medicine. PubMed ID: 23628838
• Muszynski, Jennifer A. MD; Sartori, James RN, BSN; Steele, Lisa RN, BSN. Multidisciplinary Quality Improvement Initiative to Reduce Ventilator-Associated Tracheobronchitis in the PICU.  Critical Care Medicine. PubMed ID: 23628838

• Fellow, American Academy of Pediatrics
• Member, American Medical Association
• Member, Society of Critical Care Medicine (SCCM)